APA (7th ed.) Citation

SM, B., K, A., PA, G., NMS, G., JA, S., LF, D., . . . AM, K. (2022). Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75(1), e792. https://doi.org/10.1093/cid/ciab823

Chicago Style (17th ed.) Citation

SM, Bueno, et al. "Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 75, no. 1 (2022): e792. https://doi.org/10.1093/cid/ciab823.

MLA (9th ed.) Citation

SM, Bueno, et al. "Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 75, no. 1, 2022, p. e792, https://doi.org/10.1093/cid/ciab823.